Internal Reference Number: FOI_7106
Date Request Received: 31/03/2023 00:00:00
Date Request Replied To: 11/04/2023 00:00:00
This response was sent via: By Email
Request Summary: Dabrafenib + Trametinib in cancer treatment
Request Category: Private Individuals
| Question Number 1: I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment. A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib: i) Metastatic Melanoma ii) Adjuvant Melanoma iii) BRAF mutated Lung Cancer | |
| Answer To Question 1: i) We don’t treat melanoma with SACt at this Trust ii) We don’t treat melanoma with SACt at this Trust iii) <5 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
